Amiloride

Quick links to important sections

Amiloride

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amiloride

Property Description
Active Ingredient Amiloride Hydrochloride
Form Oral Tablet
Pharmacological Class Potassium-Sparing Diuretic
Common Use Managing high blood pressure and edema
Origin Synthetic

What Type of Medicine is Amiloride?

Amiloride is a prescription medication whose active ingredient, amiloride hydrochloride, is an International Nonproprietary Name (INN) belonging to the pharmacological class known as potassium-sparing diuretics. The drug is a completely synthetic compound, produced in a laboratory setting. This classification indicates its unique principle of increasing the excretion of water and sodium from the body via the kidneys while strategically retaining potassium. This potassium-sparing effect is the defining feature that differentiates it from other diuretics.


What is Amiloride Used for Generally?

The primary general purpose of Amiloride is to assist the body in eliminating excess salt and water, which is used to manage fluid retention (edema) and high blood pressure (hypertension). Amiloride is rarely used alone; instead, it is most often prescribed as a crucial component in a fixed-dose combination alongside a thiazide diuretic (such as hydrochlorothiazide). This strategic pairing is medically recognized to enhance the overall fluid-reducing effect while simultaneously protecting the patient against the depletion of potassium, a common side effect of many high-potency diuretics.

Regulatory References

  1. Amiloride: MedlinePlus Drug Information

What side effects are possible with Amiloride?

Possible side effects and safety information

The safety profile of Amiloride is characterized primarily by its potential effects on the body’s electrolyte balance, as officially documented in prescribing information. Adverse reactions are systematically grouped by frequency and the physiological system affected.

Key Safety Consideration and Common Reactions

The most significant and serious safety characteristic noted in regulatory documents is the risk of hyperkalaemia (elevated serum potassium levels), which can lead to potentially fatal cardiac events. For this reason, Amiloride is contraindicated when serum potassium is already elevated or when used alongside other potassium-retaining agents or potassium supplements.

Less severe adverse effects are classified by frequency across various System Organ Classes (SOC):

System Organ Class Common Reactions (Documented ge 1%)
Nervous System Headache, dizziness, fatigue, weakness
Gastrointestinal Nausea, vomiting, diarrhoea, abdominal pain
Metabolism Hyperkalaemia (risk of), loss of appetite

Population-Specific and Time-Related Safety

The risk of developing serious adverse reactions is significantly amplified in certain patient groups. Individuals with impaired renal function (kidney disease) or diabetes mellitus are officially documented as being at a much higher risk of hyperkalaemia. Use in the pediatric population is not established. Furthermore, the official label notes that orthostatic hypotension (dizziness upon standing) is a pattern that is more common when treatment is first initiated.

Overdose and Emergency Response

Amiloride overdose is characterized primarily by profound fluid and electrolyte disturbances, with the most significant manifestation being Hyperkalemia (elevated potassium levels). This can present with systemic symptoms such as paresthesias, muscular weakness, fatigue, flaccid paralysis of the extremities, mental confusion, and dizziness. Severe overdose is a life-threatening scenario, carrying the risk of shock, seizures, and potentially fatal cardiovascular events, including bradycardia and specific ECG abnormalities like QRS widening.

The official regulatory guidance requires the immediate discontinuation of Amiloride at the earliest sign of Hyperkalemia. Urgent medical attention is mandatory: individuals experiencing collapse, seizures, or breathing difficulty must prompt an immediate call to emergency services. In all suspected cases, poison control or the emergency room should be contacted at once.

Treatment is symptomatic and supportive, as no specific antidote is available. Procedures include measures to actively reduce potassium levels, such as the administration of sodium bicarbonate or insulin and glucose, particularly if potassium exceeds 6.5 mEq per liter. Patients require close observation and careful ECG monitoring. The risk of severe hyperkalemia is accentuated in populations with renal impairment, the elderly, and diabetic patients.

Therapeutic Uses of Amiloride

Amiloride is commonly used in treatment regimens to address conditions that involve symptomatic fluid management.

The primary therapeutic applications include managing edema (swelling) and high blood pressure (hypertension), often in conjunction with other medicines.

What Amiloride Treats: Main Uses and Benefits

Amiloride is commonly used to help with symptoms related to fluid overload, which may include noticeable swelling in the legs and ankles. It is relevant in clinical settings marked by conditions like congestive heart failure and hypertension, where effective fluid management is necessary. The medication supports adjunctive management, especially when fluid retention is a key clinical concern.

The major benefit of Amiloride is its role in maintaining potassium levels while helping to manage symptoms related to systemic imbalance. This supports patients who are taking other diuretics, as it may assist with managing associated symptoms like muscle weakness and fatigue caused by potassium depletion. The combination of fluid reduction and electrolyte protection contributes to easing discomfort and assists with maintaining functional stability during periods of heightened symptoms.


Quick Fact: Support for Swelling & Blood Pressure

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Official Eligibility Rules for Amiloride

Eligibility for Amiloride is strictly defined by regulatory documents, focusing heavily on conditions that increase the risk of elevated potassium levels (hyperkalemia).


Absolute Contraindications

The medicine must not be used by individuals who have a serum potassium level of mathbf5.5 mEq/L or higher, or those currently taking potassium supplements or other potassium-sparing agents (e.g., spironolactone). Use is also strictly contraindicated in patients with severe renal functional impairment, including anuria, acute or chronic renal insufficiency, and established diabetic nephropathy.


Restricted and Conditional Use

Population Group Regulatory Status
Pediatric Patients Safety and effectiveness have not been established; use is generally not recommended.
Older Adults Use requires caution due to increased risk of hyperkalemia.
Diabetes Mellitus Should be avoided if possible; requires careful, frequent monitoring if used.
Pregnancy/Lactation Conditional use (FDA Category B for pregnancy); not recommended during lactation due to lack of data.
Severe Liver Disease Use requires caution due to the risk of precipitating hepatic coma.

Eligibility is limited to adult patients receiving specific other diuretics, provided they are free of the contraindications listed above.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Amiloride's official regulatory profile is structured around the risk of additive effects on the body's electrolyte and fluid balance, particularly concerning potassium levels.

Documented High-Risk Combinations

Co-administration with other potassium-sparing diuretics (such as Spironolactone or Triamterene) or any form of potassium supplementation (medication or salt substitutes) is formally contraindicated. This restriction is due to the severe and rapid risk of developing hyperkalemia (abnormally high potassium levels) as stated in government prescribing information.

Other Clinically Significant Interactions

  • ACE Inhibitors and ARBs: Combining Amiloride with Angiotensin-Converting Enzyme (ACE) Inhibitors or Angiotensin II Receptor Blockers (ARBs) involves a documented increased risk of hyperkalemia due to additive potassium-retaining effects.
  • Lithium: Amiloride may reduce the renal clearance of Lithium, leading to higher plasma concentrations of Lithium and an increased risk of toxicity.
  • NSAIDs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as Indomethacin, may reduce the diuretic and antihypertensive effects of Amiloride.
  • Population Notes: The risk of hyperkalemia is officially noted as accentuated in patients with impaired renal function and those with diabetes mellitus, requiring frequent monitoring and sometimes necessitating avoidance.

Mechanism of Action

Amiloride acts by directly intervening in the final segment of the kidney's filtering unit (the nephron). Its mechanism is defined by selective action and involves a unique two-step consequence: inhibiting sodium reabsorption while simultaneously conserving potassium.

Molecular Blockade of ENaC

Amiloride's core mechanism is the targeted blockade of the Epithelial Sodium Channel (ENaC) . These channels, located on the apical membrane of principal cells in the collecting duct, mediate the final re-entry of sodium ( Na^+) from the forming urine back into the body. By physically occluding the ENaC pore, the drug prevents Na^+ reabsorption, causing more sodium and, osmotically, more water to be delivered to the urine (natriuresis).

Electrical Basis for Potassium Sparing

The inhibition of Na^+ reabsorption electrically impacts the tubule, reducing the lumen-negative potential difference normally created by sodium movement. This reduction in the electrical force is the essential mechanism that decreases the secretion of positively charged potassium ( K^+) and hydrogen ( H^+) ions into the tubular fluid, leading to the physiological effect of potassium conservation (antikaliuresis). This K^+-sparing mechanism is employed in combination therapy to modulate the kaliuretic effect of co-administered diuretics.

Dosage and Administration Information

Amiloride is administered exclusively via the oral route in the form of an immediate-release tablet. It is often prescribed as an adjunctive treatment in a fixed-dose combination with a thiazide diuretic, although it is also available as a single agent.

Official Dosing and Frequency

The standard adult starting dose is typically 5 mg taken once daily. Depending on the regimen, the initial daily dose may also be 10 mg, which can be administered as a single dose or divided into 5 mg doses twice daily. The dose is adjusted based on patient response, with the typical maintenance dose ranging between 5 mg and 10 mg daily. The daily dose may be increased up to a maximum of 20 mg. The treatment is usually followed as a long-term maintenance plan.

Administration Conditions

Amiloride tablets are generally instructed to be taken with food to establish a consistent administration context. The medicine should be taken at approximately the same time every day. If a dose is missed, the dose should be taken as soon as it is remembered, unless it is almost time for the next scheduled dose, in which case the missed dose should be skipped; doses should not be doubled.

Population-Specific Use

For older adults and patients with any degree of renal impairment, the dosage must be carefully adjusted and monitored due to potential changes in drug clearance. The safety and efficacy of Amiloride use have not been established in pediatric patients (children under 18), and its use in this population is generally not recommended.

Recent Clinical Evidence

This overview summarizes the research and clinical trials that have been conducted to evaluate Amiloride, describing what studies explored and what their findings suggest, without providing any medical or clinical guidance.


Evidence for Use in Managing High Blood Pressure (Hypertension)

Amiloride was studied for its use in managing high blood pressure, or hypertension, primarily through Randomized Controlled Trials (RCTs). These studies typically used a comparative design, examining Amiloride when combined with other medications. Research explored changes related to reaching target blood pressure goals and monitored metabolic factors like potassium levels, particularly in patients with Resistant Hypertension (uncontrolled high blood pressure despite existing treatment). Evidence is largely focused on the drug's use as an add-on therapy rather than as a treatment by itself.


Evidence for Use in Managing Fluid Retention (Edema)

Amiloride was studied for its use in managing fluid retention, or edema, in conditions like Congestive Heart Failure and certain kidney conditions. Acute intervention trials and pilot studies explored fluid balance by tracking changes in body weight and urine volume. A key focus was examining the influence of the drug on maintaining potassium levels while promoting the excretion of salt and water. Findings show patterns related to fluid balance when Amiloride was used alongside other diuretics.


Research Limitations and Gaps

The current research landscape highlights several limitations. Evidence is often derived from small-scale pilot studies with modest sample sizes, particularly for specific edema conditions. Follow-up durations were limited in many key comparative trials, meaning long-term outcomes are not fully established through extensive controlled research. Data for certain groups, such as children or pregnant individuals, remain insufficient in the primary regulatory research summaries.

Key Studies & References

  1. Amiloride Hydrochloride and Hydrochlorothiazide Tablets, USP (Drug Monograph for Combination Use)
  2. Dose doubling, relative potency, and dose equivalence of potassium-sparing diuretics affecting blood pressure and serum potassium: Systematic review and meta-analyses

Frequently Asked Questions (FAQ)

Common questions about Amiloride (FAQ)


Q: Is Amiloride the same as a water pill?

A: Amiloride is classified as a diuretic, which is the medical term for a medication that is often referred to by patients as a "water pill." Official prescribing information describes it as assisting the kidneys in removing excess salt and water from the body, while also helping the body retain potassium.


Q: What is the main difference between Amiloride and Spironolactone?

A: Both Amiloride and Spironolactone are categorized as potassium-sparing diuretics. However, official documents describe them as having different mechanisms of action. Amiloride directly works by blocking the Epithelial Sodium Channel (ENaC), while Spironolactone works by blocking mineralocorticoid receptors in the kidneys.


Q: What happens if I stop taking Amiloride suddenly?

A: Regulatory guidance describes that the treatment plan should be reviewed by a healthcare provider before any changes. Abrupt discontinuation of the treatment is generally not discussed in official product information, emphasizing that the medication should be taken exactly as prescribed.


Q: How quickly does Amiloride start working to lower blood pressure?

A: The onset of the diuretic effect, which is the immediate action in the kidneys, typically begins within two hours after a dose. The maximum or peak effect of the diuresis generally occurs between six and ten hours following administration, as documented in regulatory pharmacokinetics summaries.


Q: Is Amiloride considered a strong diuretic?

A: Regulatory product information generally describes Amiloride as having relatively weak natriuretic, diuretic, and blood pressure-lowering activity. Due to this relative activity, Amiloride is often prescribed in fixed-dose combinations with other diuretics.


Q: How long does the effect of one dose of Amiloride last?

A: According to the Summary of Product Characteristics (SmPC) from regulatory bodies, the effect of a single dose of Amiloride generally persists for approximately 24 hours. This duration aligns with its common use as a once-daily maintenance treatment.


Q: Are there foods I should specifically avoid while taking Amiloride?

A: The official warnings focus primarily on potential drug interactions and the risk of elevated potassium. Regulatory documents state that Amiloride is formally contraindicated for use with any potassium supplementation or potassium-containing salt substitutes. This restriction is due to the severe and rapid risk of developing high potassium levels.


Q: Can I take Amiloride if I also take supplements like magnesium?

A: Regulatory documents do not list specific interaction warnings for magnesium supplements. However, the official prescribing information describes that use requires caution and monitoring in patients who have pre-existing conditions that cause low magnesium levels, as this is a known electrolyte that needs to be balanced.


Q: What type of blood tests are typically done when taking Amiloride?

A: Official product information indicates that the treatment requires frequent monitoring of the patient's blood due to the risk of high potassium. This monitoring includes checking serum electrolytes, specifically potassium, as well as kidney function indicators like creatinine and Blood Urea Nitrogen (BUN) levels.


Q: Does Amiloride cause frequent urination?

A: As a diuretic, the medicine increases urine production. Therefore, an increase in urine production and more frequent urination are expected effects of this type of medication, and this is noted in patient information.


Q: Are there specific symptoms that mean Amiloride is causing high potassium?

A: The most serious risk documented in official warnings is high potassium, known as hyperkalemia. Specific warning signs for this condition can include unusual tiredness, numbness or tingling in the hands, feet, or lips, muscle weakness or limp feeling, and an irregular heartbeat.


Q: Is there a generic version of Amiloride available?

A: Yes, Amiloride is widely available as a generic medication. While the drug was previously available under the brand name Midamor, regulatory sources indicate that the brand name product is generally no longer marketed.


Q: How does Amiloride compare to Thiazide diuretics in mechanism?

A: Official information defines Amiloride’s mechanism as directly blocking sodium channels in the final part of the kidney’s filtering system. In contrast, thiazide diuretics work by blocking a different salt transport system in a section higher up in the kidney tubule.


Q: What is the risk of dehydration when taking Amiloride?

A: Official product information advises caution regarding fluid loss, as the drug increases the amount of water excreted by the body. Regulatory information indicates that the patient's fluid status requires monitoring to manage the risk of excessive fluid loss. Furthermore, use is generally restricted or contraindicated in patients who are already experiencing hypovolemia or dehydration.


Q: Are there any known interactions between Amiloride and alcohol?

A: Official warnings for the combination product (Amiloride with a thiazide) advise caution regarding alcohol consumption. Using alcohol alongside this medication may increase the risk of developing dangerously low blood pressure, particularly when rising from a sitting or lying position (orthostatic hypotension).


Q: Is it normal to have muscle cramps while taking a diuretic like Amiloride?

A: Yes, regulatory documents list muscle cramps as a potential adverse reaction. This reaction is generally related to the medication's effects on the body's electrolytes and fluid balance.


Q: Are there different brand names for the drug Amiloride?

A: Amiloride is the active ingredient and the common generic name. The most well-known brand name was Midamor, which is generally no longer available. The drug is now primarily marketed as the generic version.

How should Amiloride be stored and disposed of?

How to Store and Dispose of Amiloride?

Amiloride tablets must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F). The medication should be kept in a tightly closed container and stored away from heat and moisture; do not store it in a bathroom.

To ensure safety, amiloride must be stored strictly out of the sight and reach of children.

For disposal, unused or expired tablets should be managed through a drug take-back program if one is available. If no program exists, the tablets should not be flushed down the toilet. Instead, they may be mixed with an unpalatable substance (like dirt or cat litter), sealed in a bag, and then discarded in the household trash, as specified by official regulatory documents.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amiloride found in:

A-Z Index: